SCHEMBL198524

SCHEMBL198524

CCCCCCCCCCCCCCCCCCCc1[c]c(CCCCCCCCCCCCCCCCCCC)ccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 3/20 0.52
GPR84 Q9NQS5 1/20 0.44
LIPG Q9Y5X9 3/20 0.42
ESR1 P03372 2/20 0.42
ADRA2A P08913 2/20 0.42
ADORA3 P0DMS8 2/20 0.42
TACR2 P21452 2/20 0.42
SLC6A2 P23975 2/20 0.42
SLC6A4 P31645 2/20 0.42
SLC6A3 Q01959 2/20 0.42
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 1/20 0.42
LMNA P02545 1/20 0.42
SHBG P04278 1/20 0.42
TP53 P04637 1/20 0.42
CYP3A4 P08684 1/20 0.42
HSPD1 P10809 1/20 0.42
ADRB3 P13945 1/20 0.42
HTR2C P28335 1/20 0.42
HSPE1 P61604 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL198237 1.00 KCNH2 (0.52) KCNH2GPR84LIPGESR1ADRA2A
SCHEMBL198833 1.00 KCNH2 (0.52) KCNH2GPR84LIPGESR1ADRA2A
SCHEMBL200132 1.00 KCNH2 (0.52) KCNH2GPR84LIPGESR1ADRA2A
SCHEMBL200062 1.00 KCNH2 (0.52) KCNH2GPR84LIPGESR1ADRA2A
SCHEMBL198352 1.00 KCNH2 (0.52) KCNH2GPR84LIPGESR1ADRA2A
SCHEMBL198223 1.00 KCNH2 (0.52) KCNH2GPR84LIPGESR1ADRA2A
SCHEMBL198408 1.00 KCNH2 (0.52) KCNH2GPR84LIPGESR1ADRA2A
SCHEMBL201321 1.00 KCNH2 (0.52) KCNH2GPR84LIPGESR1ADRA2A
SCHEMBL199031 1.00 KCNH2 (0.52) KCNH2GPR84LIPGESR1ADRA2A
SCHEMBL200075 1.00 KCNH2 (0.52) KCNH2GPR84LIPGESR1ADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8088922-B2 Dibenzorylenetetracarboximides as infrared absorbers BASF AKTIENGESELLSCHAFT (DE) 2012-01-03 US disclosed
EP-2029573-B1 DIBENZORYLENETETRACARBOXIMIDES AS INFRARED ABSORBERS BASF SE (DE) 2011-10-26 EP disclosed
US-20100048904-A1 DIBENZORYLENETETRACARBOXIMIDES AS INFRARED ABSORBERS BASF AKTIENGESELLSCHAFT (DE) 2010-02-25 US disclosed
EP-2029573-A1 DIBENZORYLENETETRACARBOXIMIDES AS INFRARED ABSORBERS BASF SE (DE) 2009-03-04 EP disclosed
WO-2007138051-A1 DIBENZORYLENETETRACARBOXIMIDES AS INFRARED ABSORBERS BASF SE (DE) 2007-12-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048904-A1 DIBENZORYLENETETRACARBOXIMIDES AS INFRARED ABSORBERS TDO2, C9, CYP3A43 KCNH2 1669/4885GPR84 2593/4885LIPG 3346/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.